Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04661072 · ClinicalTrials.gov registry record
Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care
A clinical trial of Congenital Uterine Anomaly, sponsored by Yale University.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT04661072: Recruiting study of Congenital Uterine Anomaly, sponsored by Yale University.
NCT04661072 is a study of Congenital Uterine Anomaly that is actively recruiting participants, run by Yale University. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04661072, a study of Congenital Uterine Anomaly, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to learn more about the health outcomes associated with congenital uterine anomalies (CUAs), and the possible environmental and genetic causes of the condition. The researchers plan to investigate whether any cancer associations (with breast, renal, ovarian, vaginal and uterine cancers) exist in females with CUAs. The investigator will also investigate any environmental and genetic factors that may be responsible for causing CUAs.
Primary Outcome
Prevalence of breast cancer in women with CUA's compared to women without CUA's will be measured
Conditions Studied
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-07-14 |
| Est. Completion | 2027-08 |
What NCT04661072 shows while recruiting
NCT04661072 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Congenital Uterine Anomaly appearing as the primary indexed condition, and to 0 interventions.
NCT04661072 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04661072 about?
NCT04661072 is a clinical study titled "Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care". The purpose of this research study is to learn more about the health outcomes associated with congenital uterine anomalies (CUAs), and the possible environmental and genetic causes of the condition. The researchers plan to investigate whether any cancer associations (with breast, renal, ovarian, vag...
What is the current status of trial NCT04661072?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2021-07-14. Estimated completion is 2027-08.
What conditions does trial NCT04661072 study?
This clinical trial studies the following conditions: Congenital Uterine Anomaly.
Who is sponsoring clinical trial NCT04661072?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04661072 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI